Favipiravir is influenza/antiviral medicine. It selectively inhibits the RNA polymerase of the influenza virus, an enzyme required for viral replication once human host are infected. it is believed that Favipiravir may be effective in treating COVID-19. Favipiravir is only used when there is an outbreak of novel or re-emerging influenza virus infections in which other influenza antiviral drugs are either not effective or insufficiently effective.
Dosage & Administration
The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by sicians. The total treatment duration should be 5 days.
Interaction
In animal studies, decreased RBC production, and increases in liver function parameters such as AST, ALP, ALT, and total bilirubin, and increased vacuolization in hepatocytes. rmation regarding Favipiravir in humans is not readily available.
Contraindications
Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.
Signup today to claim your Discount. Get Started before it's too late!
